Colorectal cancer epidemiology: world trends and incidence of colon cancer in the Republic of Uzbekistan in 2012–2017
https://doi.org/10.17650/2686-9594-2020-10-1-56-63
Abstract
Objective: epidemiological evaluation of global trends in colorectal cancer and assessment of colon cancer incidence in the Republic of Uzbekistan in 2012–2017.
Materials and methods. We used GLOBOCAN data to analyze the situation with colorectal cancer worldwide. We also assessed the incidence of colon cancer, trends, and mean age of patients (by years) registered in the Republic of Uzbekistan. This article emphasizes the need for epidemiological studies of colorectal cancer in Uzbekistan.
Results. World trends in colorectal cancer incidence and mortality indicate that these parameters vary across different regions and depend on the economic situation. There are also some sex differences: men are more likely to develop colorectal cancer than women (male to female ratio 1.25:1.0). The number of patient died of colorectal cancer is growing; the male to female ratio is 1.22:1.0.
Conclusions. Our assessment of epidemiological situation of colon cancer in the Republic of Uzbekistan demonstrated that its incidence tends to increase, which necessitates further research evaluating regional differences and risk factors for colorectal cancer.
About the Authors
S. N. NavruzovUzbekistan
3 Kara-kamysh St., 100098 Tashkent, Uzbekistan
D. A. Alieva
Uzbekistan
3 Kara-kamysh St., 100098 Tashkent, Uzbekistan
E. E. Kulmiev
Uzbekistan
3 Kara-kamysh St., 100098 Tashkent, Uzbekistan
References
1. Parkin D.M., Whelan S.L., Ferlay J. et al. Cancer Incidence in five Continents. Vol. 8. Lyon: IARC, 2003.
2. Ferlay J., Soerjomataram I., Ervik M. et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon: IARC, 2013. Available at: http://globocan.iarc.fr.
3. Aliev V.A., Barsukov Yu.A., Nikolaev A.V. et al. Colorectal cancer with synchronous distant metastases: rationale for cytoreductive surgeries and outlooks – surgeon’s view. Onkologicheskaya proktologiya = Proctologic Oncology 2012;(4):15–21. (In Russ.)
4. Aksel E.M., Gerasimenko V.N., Dvoyrin V.V. Social and economic aspects of organizing cancer control. Moscow: Ministry of Health of the Russian Federation, 2011. (In Russ.)
5. Davydov M.I., Aksel E.M. Malignant tumors in Russia and CIS countries in 2012. Moscow: MIA, 2014. (In Russ.)
6. Aksel E.M., Dvoyrin V.V. A method for assessing socio-economic damage caused by cancer deaths. Guidelines. Moscow, 1984. (In Russ.)
7. Davydov M.I., Aksel E.M. Malignant tumors in Russia and CIS countries in 2012. Moscow: MIA, 2016. (In Russ.)
8. Situation with cancer care in Russia in 2016. Ed. by A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: P.A. Herzen Moscow Oncology Research Institute, 2017. 236 p. (In Russ.)].
9. Dyatchenko O.T., Shabashova N.Ya., Kozhevnikov S.Yu. et al. Socio-economic problems of cancer control. General Oncology. Guideline for physicians. Moscow: 2012. Pp. 334–352. (In Russ.)].
10. Situation with cancer care in Russia in 2014. Ed. by A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: P.A. Herzen Moscow Oncology Research Institute, 2016. 235 p. (In Russ.)
11. Kovalenko B.S., Golivets T.P. Analysis of global and Russian trends in cancer incidence in the 21st century. Meditsina i farmatsiya = Medicine and Pharmacy 2015;1(4):23–8. (In Russ.)
12. Forman D., Ferlay J. The global and regional burden of cancer (2014). Cancer worldwide. World Cancer Report 2014. Рp. 16–53.
13. WHO Mortality Database. Available at: http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html.
14. Merabishvili V.M. Malignanttumors in the world, Russia, and Saint Petersburg. Saint Petersburg: KOSTA, 2012. (In Russ.)
15. Ferlay J., Parkin D.M. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;4:765–81.
16. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62(1):10–29. DOI: 10.3322/caac.20138.
17. Global Initiative for Cancer Registry Development. Lyon: International Agency for Research on Cancer.
18. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388(10053):1659–724. DOI: 10.1016/S0140-6736(16)31679-8.
19. Plummer M., de Martel C., Vignat J. et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 2016;4(9):e609–16. DOI: 10.1016/S2214-109X(16)30143-7.
20. World cancer report 2014. Eds.: B.W. Stewart, C.P. Wild. Lyon: International Agency for Research on Cancer, 2014. Available at: http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014.